# Current development status — Stage 3.42, 2026-10-01

The optional sequential design/diagnostic interfaces, explicit evidence binding,
matched endpoint-velocity analysis and bounded mathematical tools are implemented.
The one live attempt stopped at the protocol-correction limit before diagnostic
report submission. The requested diagnosis–improvement–verification cycle remains
incomplete. No controller modification was adopted and no new backend run occurred.

The latest successful reach execution is still Stage 3.41,
`5991de53e82747439e87ba8569667e1b`: 7.643 mm terminal error against 10 mm tolerance.
Its sampled settling and real-time criteria failed. Historical blocked statuses
and earlier failed robot results describe their own archived stages; they do not
replace that baseline or the newer Stage 3.42 workflow failure.

Stage 3.42 used 17/24 provider attempts and exhausted the separate four-correction
protocol allowance. It also exposed a diagnostic subgrant enforcement defect,
now fixed offline. The failed live execution is retained without rewriting its
budget or provenance. A new live attempt requires a separately authorized stage;
unused project attempts do not reset its exhausted correction allowance.

Details: [implementation and outcome](stage342_diagnostic_cycle.md),
[compact evidence](../evidence/stage342_diagnostic_cycle_20261001/outcome.json).

The next physical parameter group is tendon routing and guide lever arms, only
after a valid diagnostic handoff, matched controller comparison, and braking
assessment across trajectory operating points. No routing bounds or design-space
expansion were opened here. Screening priorities and exclusions are unchanged.
